Safety of Intravenous Lidocaine Infusions
CompletedNCT01091935
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
The purpose of this study is to prospectively determine the side effects profile in adults with neuropathic pain receiving intravenous infusions of lidocaine 5 mg per kg of lean body weight, infused over 45 minutes.
Study details
- Official title
- Safety of Intravenous Lidocaine Infusions for Chronic Neuropathic Pain
- Conditions
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Collaborators
- University of Western Ontario, Canada
- Start date
- 2009-06
- Primary completion
- 2010-01
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult outpatients \> 18 years \< 80 years diagnosed with chronic neuropathic pain Exclusion Criteria: * Unable to provide informed consent * Unable to speak and understand English * Liver, kidney, or cardiac failure * Allergy to Lidocaine
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01091935